Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Bladder preservation in the treatment of muscle-invasive bladder cancer (MIBC): a review of the literature and a practical approach to therapy.

Smith ZL, Christodouleas JP, Keefe SM, Malkowicz SB, Guzzo TJ.

BJU Int. 2013 Jul;112(1):13-25. doi: 10.1111/j.1464-410X.2012.11762.x. Epub 2013 Jan 29. Review.

2.

Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.

Koga F, Fujii Y, Masuda H, Numao N, Yokoyama M, Ishioka J, Saito K, Kawakami S, Kihara K.

BJU Int. 2012 Sep;110(6 Pt B):E203-8. doi: 10.1111/j.1464-410X.2011.10874.x. Epub 2012 Jan 30.

3.

Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.

Ploussard G, Daneshmand S, Efstathiou JA, Herr HW, James ND, Rödel CM, Shariat SF, Shipley WU, Sternberg CN, Thalmann GN, Kassouf W.

Eur Urol. 2014 Jul;66(1):120-37. doi: 10.1016/j.eururo.2014.02.038. Epub 2014 Feb 26. Review.

PMID:
24613684
4.

Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.

Koga F, Kihara K, Yoshida S, Yokoyama M, Saito K, Masuda H, Fujii Y, Kawakami S.

BJU Int. 2012 Mar;109(6):860-6. doi: 10.1111/j.1464-410X.2011.10425.x. Epub 2011 Aug 19.

5.

ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.

Gakis G, Efstathiou J, Lerner SP, Cookson MS, Keegan KA, Guru KA, Shipley WU, Heidenreich A, Schoenberg MP, Sagaloswky AI, Soloway MS, Stenzl A; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.

Eur Urol. 2013 Jan;63(1):45-57. doi: 10.1016/j.eururo.2012.08.009. Epub 2012 Aug 14. Review.

PMID:
22917985
6.

Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review.

Koga F, Kihara K.

Int J Urol. 2012 May;19(5):388-401. doi: 10.1111/j.1442-2042.2012.02974.x. Epub 2012 Mar 12. Review.

7.

Therapeutic interventions targeting organ preservation in muscle-invasive bladder cancer: a review.

Koukourakis G, Kouloulias V, Zacharias G, Sotiropoulou-Lontou A, Koukourakis M.

Clin Transl Oncol. 2011 May;13(5):315-21. doi: 10.1007/s12094-011-0660-7. Review.

PMID:
21596659
8.

Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.

Maarouf AM, Khalil S, Salem EA, ElAdl M, Nawar N, Zaiton F.

BJU Int. 2011 May;107(10):1605-10. doi: 10.1111/j.1464-410X.2010.09564.x. Epub 2010 Sep 3.

9.

Trimodality bladder preservation therapy for muscle-invasive bladder cancer.

Chen RC, Shipley WU, Efstathiou JA, Zietman AL.

J Natl Compr Canc Netw. 2013 Aug;11(8):952-60.

PMID:
23946174
10.

Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients.

Koga F, Numao N, Saito K, Masuda H, Fujii Y, Kawakami S, Kihara K.

Urol Oncol. 2013 Oct;31(7):1270-5. doi: 10.1016/j.urolonc.2012.01.014. Epub 2012 Mar 2.

PMID:
22386622
11.

Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233.

Mak RH, Hunt D, Shipley WU, Efstathiou JA, Tester WJ, Hagan MP, Kaufman DS, Heney NM, Zietman AL.

J Clin Oncol. 2014 Dec 1;32(34):3801-9. doi: 10.1200/JCO.2014.57.5548. Epub 2014 Nov 3. Erratum in: J Clin Oncol. 2015 Mar 1;33(7):814.

12.

Preoperative concurrent chemoradiotherapy against muscle-invasive bladder cancer: results of partial cystectomy in elderly or high-risk patients.

Kageyama Y, Okada Y, Arai G, Hyochi N, Suzuki M, Masuda H, Hayashi T, Kawakami S, Okuno T, Ishizaka K, Kihara K.

Jpn J Clin Oncol. 2000 Dec;30(12):553-6.

PMID:
11210165
13.

EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer.

May M, Burger M, Brookman-May S, Stief CG, Fritsche HM, Roigas J, Zacharias M, Bader M, Mandel P, Gilfrich C, Seitz M, Tilki D.

Clin Genitourin Cancer. 2014 Aug;12(4):278-86. doi: 10.1016/j.clgc.2013.11.014. Epub 2013 Nov 13.

PMID:
24331576
14.

[Chemoradiotherapy for muscle-invasive cancer: methods, surveillance and results. An update from the cancer committee of the French National Association of Urology].

Quintens H, Roupret M, Larré S, Neuzillet Y, Pignot G, Compérat E, Wallerand H, Houédé N, Roy C, Soulié M, Pfister C; Membres du CC-AFU.

Prog Urol. 2012 Jan;22(1):13-6. doi: 10.1016/j.purol.2011.09.016. Epub 2011 Nov 9. French.

PMID:
22196000
15.

Organ preservation for muscle-invasive bladder cancer by transurethral resection.

Leibovici D, Kassouf W, Pisters LL, Pettaway CA, Wu X, Dinney CP, Grossman HB.

Urology. 2007 Sep;70(3):473-6.

PMID:
17905099
16.

Managing muscle-invasive bladder cancer in the elderly.

Weizer AZ, Palella GV, Montgomery JS.

Expert Rev Anticancer Ther. 2010 Jun;10(6):903-15. doi: 10.1586/era.10.71. Review.

PMID:
20553214
17.

Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.

Solsona E, Climent MA, Iborra I, Collado A, Rubio J, Ricós JV, Casanova J, Calatrava A, Monrós JL.

Eur Urol. 2009 Apr;55(4):911-9. doi: 10.1016/j.eururo.2008.08.027. Epub 2008 Aug 15.

PMID:
18722046
18.

High Ki-67 Expression Predicts Favorable Survival in Muscle-Invasive Bladder Cancer Patients Treated With Chemoradiation-Based Bladder-Sparing Protocol.

Tanabe K, Yoshida S, Koga F, Inoue M, Kobayashi S, Ishioka J, Tamura T, Sugawara E, Saito K, Akashi T, Fujii Y, Kihara K.

Clin Genitourin Cancer. 2015 Aug;13(4):e243-51. doi: 10.1016/j.clgc.2015.03.002. Epub 2015 Mar 27.

PMID:
25936588
19.

Trimodal therapy for invasive bladder cancer: is it really equal to radical cystectomy?

Mathieu R, Lucca I, Klatte T, Babjuk M, Shariat SF.

Curr Opin Urol. 2015 Sep;25(5):476-82. doi: 10.1097/MOU.0000000000000203. Review.

PMID:
26125510
20.

Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.

Shipley WU, Kaufman DS, Zehr E, Heney NM, Lane SC, Thakral HK, Althausen AF, Zietman AL.

Urology. 2002 Jul;60(1):62-7; discussion 67-8.

PMID:
12100923

Supplemental Content

Support Center